Physician profile
Colin Thomas
NPI 1871957159
$8,001.76
in general payments reported to CMS, 2019-2025
6 companies · $3,821 in 2025
The $3,821 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,181 · 2025: $3,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,181 · Travel and Lodging: $866 · Food and Beverage: $765 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,181.35 |
| Travel and Lodging | $866.48 |
| Food and Beverage | $764.93 |
| Education | $189.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acrotech Biopharma INC. | $7,059.99 | 2024-2025 | Beleodaq |
| Kyowa Kirin, INC. | $359.00 | 2024-2025 | Poteligeo |
| Ipsen Biopharmaceuticals, INC | $189.00 | 2024 | Tazverik |
| Janssen Scientific Affairs, LLC | $150.00 | 2025 | Talvey |
| Incyte Corporation | $123.06 | 2024 | Monjuvi |
| Secura Bio, INC. | $120.71 | 2025 | Copiktra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colin Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.